The relationships between schizophrenia symptom dimensions and executive functioning components

Schizophrenia Research

Volumn 124, Issue 1-3, 2010, Pages 169-175

  Clark, Laura K ^a   Warman, Debbie ^a   Lysaker, Paul H ^b,c  

^a UNIVERSITY OF INDIANAPOLIS   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Delis Kaplan Executive Function System; Executive functioning components; Schizophrenia

Indexed keywords

ADULT; AGE; ANALYTIC METHOD; ARTICLE; BRAIN FUNCTION; COGNITION; CONTROLLED STUDY; CORRELATION ANALYSIS; EDUCATION; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL FUNCTION; MOTOR RETARDATION; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PSYCHOSOCIAL WITHDRAWAL; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SYMPTOM;

ADULT; COGNITION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EXECUTIVE FUNCTION; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMANS; INHIBITION (PSYCHOLOGY); MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEVERITY OF ILLNESS INDEX;

EID: 78249236177     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2010.08.004     Document Type: Article

References (50)

1. Addington J., Addington D., Maticka-Tyndale E. Cognitive functioning and positive and negative symptoms in schizophrenia. Schizophr. Res. 1991, 5:123-134.
2. Albus M., Hubmann W., Ehrenberg C., Forcht U., Mohr F., Sobizack N., Walheim C., Hecht S. Neuropsychological impairments in first episode and chronic schizophrenia patients. Eur. Arch. Psychiatry Clin. Neurosci. 1996, 246:249-255.
3. Alptekin K., Akvardar Y., Akdede B., Dumlu K., Isik D., Pirincci F., Yahssin S., Kitis A. Is quality of life associated with cognitive impairment in schizophrenia?. Prog. Neuropsychopharmacol. 2005, 29:239-244.
4. Basso M.R., Nasrallah H.A., Olson S.C., Bornstein R.A. Neuropsychological correlates of negative, disorganized, and psychotic symptoms in schizophrenia. Schizophr. Res. 1998, 31:99-111.
5. Baxter R.D., Liddle P.F. Neuropsychological deficits associated with schizophrenic syndromes. Schizophr. Res. 1998, 30:239-249.
6. Bell M.D., Lysaker P.H., Beam-Goulet J.L., Milstein R.M., Lindenmayer J.P. Five component model of schizophrenia: assessing the factorial invariance of the Positive and Negative Syndrome Scale. Psychiatry Res. 1994, 52:295-303.
7. Benson D.F., Miller B.L. Frontal lobes: clinical and anatomic aspects. Behavioral Neurology and Neuropsychology 1997, 401-408. McGraw Hill, New York. T.E. Feinberg, M.J. Farah (Eds.).
8. Berman I., Viegner B., Merson A., Allan E., Pappas D., Green A.I. Differential relationships between positive and negative symptoms and neuropsychological deficits in schizophrenia. Schizophr. Res. 1997, 25:1-10.
9. Burgess P.W., Shallice T. The Hayling and Brixton Tests 1997, Thames Valley Test Company, Thurston, Suffolk, England.
10. Busch R.M., McBride A., Curtiss G., Vanderploeg R.D. The components of executive functioning in traumatic brain injury. J. Clin. Neuropsychol. 2005, 27:1022-1032.
11. Cascella N.G., Testa S.M., Meyer S.M., Vani A.R., Diaz-Asper C.M., Pearlson G.D., Schretlen D.J. Neuropsychological impairment in deficit vs. non-deficit schizophrenia. J. Psychiatr. Res. 2008, 42:930-937.
12. Chan R.C.K., Chen E.Y.H., Cheung E.F.C., Cheung H.K. Executive dysfunctions in schizophrenia: relationships to clinical manifestation. Eur. Arch. Psychiatry Clin. Neurosci. 2004, 254:256-262.
13. Chan R.C.K., Chen E.Y.H., Cheung E.F.C., Chen R.Y.L., Cheung H.K. The components of executive functioning in a cohort of patients with chronic schizophrenia: a multiple single-case study design. Schizophr. Res. 2006, 81:173-189.
14. Chan R.C.K., Chen E.Y.H., Law C.W. Specific executive dysfunction in patients with first-episode medication-naïve schizophrenia. Schizophr. Res. 2006, 82:51-64.
15. Cuesta M.J., Peralta V. Cognitive disorder in the positive, negative, and disorganization syndromes in schizophrenia. Psychiatry Res. 1995, 58:227-235.
16. Delis D.C., Kaplan E., Kramer J.H. Delis Kaplan Executive Function System: Technical Manual 2001, The Psychological Corporation, San Antonio.
17. Donohoe G., Robertson I.H. Can specific deficits in executive functioning explain the negative symptoms of schizophrenia? A review. Neurocase 2003, 9:97-108.
18. Donohoe G., Corvin A., Robertson I.H. Evidence that specific executive functions predict symptom variance among schizophrenia patients with a predominantly negative symptom profile. Cogn. Neuropsychiatry 2006, 11:13-32.
19. Eckman P.S., Shean G.D. Impairment in test performance and symptom dimensions of schizophrenia. J. Psychiatr. Res. 2000, 34:147-153.
20. Evans J.D., Bond G.R., Meyer P.S., Kim H.W., Lysaker P.H., Gibson P.J., Tunis S. Cognitive and clinical predictors of success in vocational rehabilitation in schizophrenia. Schizophr. Res. 2004, 70:331-342.
21. Gorsuch R.L. Factor Analysis 1983, Erlbaum, Hillsdale. second ed.
22. Greenwood K.E., Morris R., Sigmundsson T., Landau S., Wykes T. Executive functioning in schizophrenia with symptom profile and chronicity. J. Int. Neuropsychol. Soc. 2008, 14:782-792.
23. Hedden T., Yoon C. Individual differences in executive processing predict susceptibility to interference in verbal working memory. Neuropsychology 2006, 20:511-528.
24. Heinrichs R.W., Zakzanis K.K. Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 1998, 12:426-445.
25. Himelhoch S., Taylor S.F., Goldman R.S., Tandon R. Frontal lobe tasks, antipsychotic medication, and schizophrenia syndromes. Biol. Psychiatry 1996, 39:227-229.
26. Homack S., Lee D., Riccio C.A. Test review: Delis-Kaplan Executive Function System. J. Clin. Exp. Neuropsychol. 2005, 27:599-609.
27. Johnson-Selfridge M., Zalewski C. Moderator variables of executive functioning in schizophrenia: meta-analytic findings. Schizophr. Bull. 2001, 27:305-316.
28. Kay S.R., Fizszbein A., Opler L.A. The positive and negative syndrome scale for schizophrenia. Schizophr. Bull. 1987, 13:261-276.
29. Liddle P.F. Schizophrenic syndromes, cognitive performance, and neurological dysfunction. Psychol. Med. 1987, 17:49-57.
30. Liddle P.F., Morris D.L. Schizophrenic syndromes and frontal lobe performance. Br. J. Psychiatry 1991, 158:340-345.
31. Logan G.D., Cowan W.B. On the ability to inhibit thought and action: a theory of an act of control. Psychol. Rev. 1984, 91:295-327.
32. Lysaker P.H., Bell M.D., Zito W.S., Bioty S.M. Social skills at work: deficits and predictors of improvement in schizophrenia. J. Nerv. Ment. Dis. 1995, 183:688-692.
33. Lysaker P.H., Warman D.M., Dimaggio G., Procacci M., Larocca V.A., Clark L.K., Dike C.A., Nicolo G. Metacognition in schizophrenia: associations with multiple assessments of executive function. J. Nerv. Ment. Dis. 2008, 196:384-389.
34. Mahurin R.K., Velligan D.I., Miller A.L. Executive-frontal lobe cognitive dysfunction in schizophrenia: a symptom subtype analysis. Psychiatry Res. 1998, 79:139-149.
35. Medalia A., Lim R. Treatment of cognitive dysfunction in psychiatric disorders. J. Psychiatr. Pract. 2004, 10:12-25.
36. Miyake A., Friedman N.P., Emerson M.J., Witzki A.H., Howerter A., Wager T.D. The unity and diversity of executive functions and their contributions to complex "frontal lobe" tasks: a latent variable analysis. Cogn. Psychol. 2000, 41:49-100.
37. Moritz S., Andreasen B., Jacobsen D., Mersmann K., Wilke U., Lambert M., Naber D., Krausz M. Neuropsychological correlates of schizophrenic syndromes in patients treated with atypical neuroleptics. Eur. Psychiatry 2001, 16:354-361.
38. Norman R.M.G., Malla A.K., Morrison-Stewart S.L., Helmes E., Williamson P.C., Thomas J., Cortese L. Neuropsychological correlates of syndromes in schizophrenia. Brit. J. Psychiat. 1997, 170:134-139.
39. Norman D.A., Shallice T. Attention and action: willed and automatic control of behaviour (CHIP Report No. 9). San Diego: University of California. 1980.
40. O'Leary D.S., Flaum M., Kesler M.L., Flashman L.A., Arndt S., Andreasen N.C. Cognitive correlates of the negative, disorganized, and psychotic symptom dimensions of schizophrenia. J. Neuropsychiatry Clin. Neurosci. 2000, 12:4-15.
41. Penades R., Catalan R., Salamero M., Boget T., Puig O., Guarch J., Gasto C. Cognitive remediation therapy for outpatients with chronic schizophrenia: a controlled and randomized study. Schizophr. Res. 2006, 87:323-331.
42. Savilla K., Kettler L., Galletly C. Relationship between cognitive deficits, symptoms and quality of life in schizophrenia. Aust. NZ J. Psychiatry 2008, 42:496-504.
43. Shallice T. From Neuropsychology to Mental Structure 1988, Cambridge University Press, Cambridge, UK.
44. Spitzer R., Gibbon M., First M. Structured Clinical Interview for DSM IV 1994, Biometrics Research, New York.
45. St.Clair-Thompson H.L., Gathercole S.E. Executive functions and achievements in school: shifting, updating, inhibition, and working memory. Q. J. Exp. Psychol. 2006, 59:745-759.
46. Tabachnick B.G., Fidell L.S. Using Multivariate Statistics 1996, Harper Collins, New York. third ed.
47. Van Der Does A.J.W., Dingemans A.J., Linszen D.H., Nutger M.A., Scholte W.F. Symptom dimensions and cognitive and social functioning in recent-onset schizophrenia. Psychol. Med. 1993, 23:745-753.
48. Voruganti L.N.P., Heslegrave R.J., Awad A.G. Neurocognitive correlates of positive and negative syndromes in schizophrenia. Can. J. Psychiatry 1997, 42:1066-1071.
49. Weintraub D., Moberg P.J., Culbertson W.C., Duda J.E., Katz I.R., Stern M.B. Dimensions of executive function in Parkinson's disease. Dement. Geriatr. Cogn. 2005, 20:140-144.
50. Zakzanis K.K. Neuropsychological correlates of positive vs. negative schizophrenic symptomatology. Schizophr. Res. 1998, 29:227-233.